Remedium Lifecare [REMLIFE] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Remedium Lifecare

BSE
Loading...

Sequent Scientific

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Remedium Lifecare wins in 6 metrics, Sequent Scientific wins in 13 metrics, with 0 ties. Sequent Scientific appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRemedium LifecareSequent ScientificBetter
P/E Ratio (TTM)25.17157.76Remedium Lifecare
Price-to-Book Ratio1.416.44Remedium Lifecare
Debt-to-Equity Ratio2,600.5162.47Sequent Scientific
PEG Ratio0.321.32Remedium Lifecare
EV/EBITDA3,209.7330.37Sequent Scientific
Profit Margin (TTM)1.17%1.85%Sequent Scientific
Operating Margin (TTM)1.65%7.56%Sequent Scientific
EBITDA Margin (TTM)1.65%7.56%Sequent Scientific
Return on Equity4.85%2.84%Remedium Lifecare
Return on Assets (TTM)0.12%1.37%Sequent Scientific
Free Cash Flow (TTM)$-11.44B$442.73MSequent Scientific
1-Year Return-83.46%14.50%Sequent Scientific
Price-to-Sales Ratio (TTM)0.302.84Remedium Lifecare
Enterprise Value$12.80B$50.45BSequent Scientific
EV/Revenue Ratio2.903.15Remedium Lifecare
Gross Profit Margin (TTM)4.88%46.86%Sequent Scientific
Revenue per Share (TTM)$8$64Sequent Scientific
Earnings per Share (Diluted)$0.06$1.15Sequent Scientific
Beta (Stock Volatility)1.200.91Sequent Scientific
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Remedium Lifecare vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Remedium Lifecare
Sequent Scientific
Remedium Lifecare Stock Overview | Sequent Scientific Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare0.00%-1.32%14.50%57.89%-29.58%-70.41%
Sequent Scientific3.87%8.21%13.07%2.39%51.46%7.55%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare-83.46%-98.90%-96.94%-96.94%-96.94%-96.94%
Sequent Scientific14.50%86.47%35.74%34.70%34.70%34.70%

News Based Sentiment: Remedium Lifecare vs Sequent Scientific

Remedium Lifecare

News based Sentiment: POSITIVE

Remedium Lifecare experienced a significant month with a major contract win in the UK and approval for a substantial rights issue. These developments, coupled with positive Q1 FY26 results, suggest a potential turning point for the company and a strengthening investment case, despite some insider selling activity.

View Remedium Lifecare News Sentiment Analysis

Sequent Scientific

News based Sentiment: POSITIVE

September was a highly positive month for Sequent Scientific, driven by exceptionally strong Q1 FY26 financial results and favorable analyst recommendations. The increasing institutional investment and optimistic price targets further reinforce the positive investment narrative, suggesting a strong growth trajectory for the company.

View Sequent Scientific News Sentiment Analysis

Performance & Financial Health Analysis: Remedium Lifecare vs Sequent Scientific

MetricREMLIFESEQUENT
Market Information
Market Cap i₹1.33B₹46.87B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,810,708479,608
90 Day Avg. Volume i8,468,759496,709
Last Close₹1.50₹198.59
52 Week Range₹0.80 - ₹9.34₹117.35 - ₹240.70
% from 52W High-83.94%-17.49%
All-Time High₹4,547.80 (Jul 03, 2023)₹336.50 (Jun 28, 2021)
% from All-Time High-99.97%-40.98%
Growth Metrics
Quarterly Revenue Growth0.46%0.13%
Quarterly Earnings Growth1.84%1.20%
Financial Health
Profit Margin (TTM) i0.01%0.02%
Operating Margin (TTM) i0.02%0.08%
Return on Equity (TTM) i0.05%0.03%
Debt to Equity (MRQ) i2,600.5162.47
Cash & Liquidity
Book Value per Share (MRQ)₹1.07₹28.19
Cash per Share (MRQ)₹0.02₹2.52
Operating Cash Flow (TTM) i₹-16,381,918,000₹360.47M
Levered Free Cash Flow (TTM) i₹21.29M₹218.78M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Remedium Lifecare vs Sequent Scientific

MetricREMLIFESEQUENT
Price Ratios
P/E Ratio (TTM) i25.17157.76
Forward P/E iN/A35.92
PEG Ratio i0.321.32
Price to Sales (TTM) i0.302.84
Price to Book (MRQ) i1.416.44
Market Capitalization
Market Capitalization i₹1.33B₹46.87B
Enterprise Value i₹12.80B₹50.45B
Enterprise Value Metrics
Enterprise to Revenue i2.903.15
Enterprise to EBITDA i3,209.7330.37
Risk & Other Metrics
Beta i1.200.91
Book Value per Share (MRQ) i₹1.07₹28.19

Financial Statements Comparison: Remedium Lifecare vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)REMLIFESEQUENT
Revenue/Sales i₹1.13B₹4.41B
Cost of Goods Sold i₹1.08B₹2.35B
Gross Profit i₹55.35M₹2.07B
Research & Development iN/AN/A
Operating Income (EBIT) i₹18.71M₹333.50M
EBITDA i₹18.71M₹505.30M
Pre-Tax Income i₹57.12M₹255.20M
Income Tax i₹10.64M₹79.50M
Net Income (Profit) i₹46.49M₹175.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)REMLIFESEQUENT
Cash & Equivalents i₹2.82M₹626.60M
Total Current Assets i₹17.20B₹8.74B
Total Current Liabilities i₹16.76B₹5.05B
Long-Term Debt i₹0₹3.00B
Total Shareholders Equity i₹438.91M₹7.70B
Retained Earnings iN/A₹1.25B
Property, Plant & Equipment i₹83,000₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)REMLIFESEQUENT
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFESEQUENT
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,810,708479,608
Average Daily Volume (90 Day) i8,468,759496,709
Shares Outstanding i577.65M249.89M
Float Shares i301.99M117.77M
% Held by Insiders i0.23%0.53%
% Held by Institutions i0.00%0.13%

Dividend Analysis & Yield Comparison: Remedium Lifecare vs Sequent Scientific

MetricREMLIFESEQUENT
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A